Risk of muscle problems, which may be serious, including muscle breakdown which can result in kidney damage. Perform LFTs before treatment initiation & thereafter when clinically indicated. Reports of increases in HbA1c & fasting serum glucose levels. Rare post-marketing reports of cognitive impairment (eg, memory loss, forgetfulness, amnesia, memory impairment, confusion). Use 80-mg dose only in patients who have been taking this dose for ≥12 mth w/o evidence of muscle toxicity. Do not start 80-mg dose in new patients, including patients already taking lower doses. Caution in patients w/ severe resp failure; kidney problems; history of liver disease; underactive thyroid; any inherited muscular problems, or family history of such problems; previous muscular problems after taking any other medicines that lower cholesterol or lipid levels; problems w/ alcohol abuse; sugar intolerance. Do not drive or operate machinery if dizziness occurs. Prescribe a lower dose in patients w/ severe kidney problems. Not recommended for childn & adolescents <18 yr.